Fidelity logo

Fidelity

North America, Massachusetts, United States, Boston

Description

Fidelity Investments is a global financial services giant, widely recognized for its extensive mutual fund offerings, brokerage services, and retirement solutions. Beyond its public market activities, Fidelity also maintains a significant and active presence in the private markets, primarily through direct investments in late-stage growth companies. These private investments are typically managed by various divisions within Fidelity, leveraging the firm's vast capital base and deep analytical capabilities to identify promising private enterprises. Fidelity's approach to private investing is distinct from traditional venture capital, often focusing on established companies with proven business models and substantial market traction.

The firm's private investment strategy centers on providing growth equity to companies across diverse sectors, including technology, fintech, healthcare, and consumer goods. Fidelity is known for its patient capital approach, often taking a long-term view on its portfolio companies. With total customer assets exceeding $12.6 trillion as of late 2023, Fidelity possesses unparalleled financial firepower, enabling it to participate in some of the largest private funding rounds globally. This scale allows Fidelity to be a significant capital provider for companies seeking substantial growth capital before a potential public offering or acquisition.

Fidelity's typical first cheque sizes for direct private investments are substantial, reflecting their focus on later-stage growth equity. While specific figures can vary, their participation often involves commitments ranging from $25 million to upwards of $150 million in a single financing round. They are frequently found co-investing alongside other large institutional investors in mega-rounds. For instance, Fidelity was a notable participant in Epic Games' $1 billion funding round in 2022, underscoring their capacity for significant capital deployment. Their investment thesis often aligns with companies demonstrating strong revenue growth, clear market leadership, and a path to profitability, rather than early-stage concept validation.

Fidelity's role as a private investor provides portfolio companies with not just capital, but also the credibility and strategic insights that come from partnering with one of the world's largest financial institutions. Their extensive network and analytical resources can be valuable assets for companies navigating complex growth phases. They are generally not involved in operational management but act as a supportive financial partner, seeking to maximize long-term returns through strategic capital allocation.

Investor Profile

Fidelity has backed more than 519 startups, with 32 new investments in the last 12 months alone. The firm has led 156 rounds, about 30% of its total and boasts 235 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States, India, Canada.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 4 rounds in the past year.
  • Typical check size: $25M – $150M.

Stage Focus

  • Series C (19%)
  • Series B (15%)
  • Post Ipo Equity (13%)
  • Series D (11%)
  • Series Unknown (9%)
  • Series E (8%)
  • Private Equity (6%)
  • Series F (4%)
  • Series A (4%)
  • Series H (2%)

Country Focus

  • United States (80%)
  • India (4%)
  • Canada (4%)
  • United Kingdom (3%)
  • China (2%)
  • Australia (1%)
  • Switzerland (1%)
  • Israel (1%)
  • Germany (1%)
  • France (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Software
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Pharmaceutical
  • Manufacturing
  • Life Science
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fidelity frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 31
Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 43
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 45
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 29
Casdin Capital
North America, New York, United States, New York
Co-Investments: 30
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 96
BlackRock
North America, New York, United States, New York
Co-Investments: 54
Franklin Templeton
North America, California, United States, San Mateo
Co-Investments: 31
Invus
North America, New York, United States, New York
Co-Investments: 35
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 29

Which angels does Fidelity often collaborate with?

JD
North America, California, United States, Palo Alto
Shared Deals: 2
SR
North America, California, United States, Los Angeles
Shared Deals: 4
RW
North America, California, United States, Los Angeles
Shared Deals: 2
AB
North America, California, United States, Mecca
Shared Deals: 2
BN
North America, Massachusetts, United States, Boston
Shared Deals: 2
AW
North America, California, United States, San Francisco
Shared Deals: 2
LT
North America, California, United States, San Jose
Shared Deals: 4
JL
North America, California, United States, Los Angeles
Shared Deals: 4
MC
North America, Texas, United States, Dallas
Shared Deals: 2
EG
North America, California, United States, San Francisco
Shared Deals: 2

What are some of recent deals done by Fidelity?

Crusoe Energy Systems

Denver, Colorado, United States

Crusoe is a vertically integrated AI infrastructure company that builds and operates data centers powered by energy sources.

Artificial Intelligence (AI)EnergyEnergy ManagementOil and Gas
Series EOct 23, 2025
Amount Raised: $1,400,000,000
Kardigan

South San Francisco, California, United States

Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.

BiopharmaHealth CareMedical
Series BOct 14, 2025
Amount Raised: $254,000,000
Oura

Oulu, Oulu, Finland

Oura designs and develops wearable rings that track sleep and performance metrics for health and wellness monitoring.

B2CHealth CareInternet of ThingsMobile AppsWearables
Series EOct 14, 2025
Amount Raised: $900,000,000
Nscale

London, England, United Kingdom

Nscale provides a full-stack AI cloud platform designed for enterprise-scale workloads.

Artificial Intelligence (AI)GPUInformation TechnologyInternetTelecommunications
Series COct 1, 2025
Amount Raised: $433,000,000
Cerebras Systems

Sunnyvale, California, United States

Cerebras Systems is an AI computing system company that provides deep learning applications, super computing, and cloud services.

Artificial Intelligence (AI)ComputerHardwareSoftware
Series GSep 30, 2025
Amount Raised: $1,100,000,000
Nscale

London, England, United Kingdom

Nscale provides a full-stack AI cloud platform designed for enterprise-scale workloads.

Artificial Intelligence (AI)GPUInformation TechnologyInternetTelecommunications
Series BSep 25, 2025
Amount Raised: $1,100,000,000
Empower Semiconductor

Milpitas, California, United States

Empower Semiconductor is a technology company enabling the design of high efficiency, integrated voltage regulators in SoCs.

ManufacturingMobile DevicesSemiconductor
Series DSep 22, 2025
Amount Raised: $140,000,000
Moby

New York, New York, United States

Moby provides regular investors access to tactics that were previously only available to Wall Street's behemoths.

FinanceFinancial ServicesFinTechInformation Technology
SeedSep 17, 2025
Amount Raised: $5,000,000
Galvanize Therapeutics

San Carlos, California, United States

Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.

Health CareMedicalMedical DeviceTherapeutics
Series CSep 3, 2025
Amount Raised: $100,000,000
Treeline Biosciences

Watertown, Massachusetts, United States

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

BiotechnologyHealth CareLife ScienceMedicalPrecision Medicine
Series ASep 3, 2025
Amount Raised: $200,000,000